George Medicines

• NCT05833958

  Phase 2, Withdrawn, 0 people, 27 Apr 2023

• NCT04518306

  Phase 3, Completed, 755 people, 19 Aug 2020

• NCT04518293

  Phase 3, Completed, 1,385 people, 19 Aug 2020

• Distribution of Cardiovascular Disease Risk Based on the Updated 2023 Guideline-Recommended Australian Cardiovascular Disease Risk Algorithm and Comparison With the 2012 Algorithm: An Observational Study

  Board or leadership role, 1 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov